69 related articles for article (PubMed ID: 15906369)
1. Antiangiogenic therapy in human gastrointestinal malignancies.
Heidemann J; Binion DG; Domschke W; Kucharzik T
Gut; 2006 Oct; 55(10):1497-511. PubMed ID: 16966704
[No Abstract] [Full Text] [Related]
2. Cruciferous vegetables as a treasure of functional foods bioactive compounds: Targeting p53 family in gastrointestinal tract and associated cancers.
Mitra S; Emran TB; Chandran D; Zidan BMRM; Das R; Mamada SS; Masyita A; Salampe M; Nainu F; Khandaker MU; Idris AM; Simal-Gandara J
Front Nutr; 2022; 9():951935. PubMed ID: 35990357
[TBL] [Abstract][Full Text] [Related]
3. The prognostic significance of p53 expression in gastric cancer: a meta-analysis.
Wei K; Jiang L; Wei Y; Wang Y; Qian X; Dai Q; Guan Q
J Cancer Res Clin Oncol; 2015 Apr; 141(4):735-48. PubMed ID: 25316440
[TBL] [Abstract][Full Text] [Related]
4. Expression and Functional Analysis of Storage Protein 2 in the Silkworm, Bombyx mori.
Yu W; Wang M; Zhang H; Quan Y; Zhang Y
Int J Genomics; 2013; 2013():145450. PubMed ID: 23671839
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of survivin suppresses uro-plasminogen activator through transcription factor JunB.
Lee KH; Choi EY; Koh SA; Kim MK; Kim KO; Lee SH; Jang BI; Kim SW; Kim SW; Song SK; Choi JH; Kim JR
Exp Mol Med; 2011 Sep; 43(9):501-9. PubMed ID: 21734448
[TBL] [Abstract][Full Text] [Related]
6. COX-2 is associated with proliferation and apoptosis markers and serves as an independent prognostic factor in gastric cancer.
Mrena J; Wiksten JP; Kokkola A; Nordling S; Ristimäki A; Haglund C
Tumour Biol; 2010 Jan; 31(1):1-7. PubMed ID: 20237896
[TBL] [Abstract][Full Text] [Related]
7. Induction of apoptosis of human colon cancer cells by siRNA recombinant expression vector targeting survivin gene.
Cai M; Wang G; Tao K; Cai C
J Huazhong Univ Sci Technolog Med Sci; 2009 Feb; 29(1):45-9. PubMed ID: 19224161
[TBL] [Abstract][Full Text] [Related]
8. Apoptotic and anti-angiogenic strategies in liver and gastrointestinal malignancies.
Kountouras J; Zavos C; Chatzopoulos D
J Surg Oncol; 2005 Jun; 90(4):249-59. PubMed ID: 15906369
[TBL] [Abstract][Full Text] [Related]
9. [Angiogenesis targeting in gastro-intestinal cancers].
Meric JB
Bull Cancer; 2007; 94(7 Suppl):F207-15. PubMed ID: 17964998
[TBL] [Abstract][Full Text] [Related]
10. Synergistic inhibition of hepatocellular carcinoma growth and hepatocarcinogenesis by combination of 5-fluorouracil and angiotensin-converting enzyme inhibitor via anti-angiogenic activities.
Yanase K; Yoshiji H; Ikenaka Y; Noguchi R; Kitade M; Kaji K; Yoshii J; Namisaki T; Yamazaki M; Asada K; Tsujimoto T; Akahane T; Uemura M; Fukui H
Oncol Rep; 2007 Feb; 17(2):441-6. PubMed ID: 17203185
[TBL] [Abstract][Full Text] [Related]
11. [Antiangiogenic therapy for gastrointestinal tumors].
Lakatos G; Tulassay Z
Orv Hetil; 2008 Dec; 149(49):2317-24. PubMed ID: 19042183
[TBL] [Abstract][Full Text] [Related]
12. [Anti-angiogenic therapy for gastrointestinal tumours].
Graepler F; Gregor M; Lauer UM
Z Gastroenterol; 2005 Mar; 43(3):317-29. PubMed ID: 15765305
[TBL] [Abstract][Full Text] [Related]
13. Endogenous stimulators and inhibitors of angiogenesis in gastrointestinal cancers: basic science to clinical application.
Sund M; Zeisberg M; Kalluri R
Gastroenterology; 2005 Dec; 129(6):2076-91. PubMed ID: 16344073
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
